United States: The Curious Case of LabMD: New Developments In The "Other" FTC Data-Security Case

Last Updated: August 26 2014
Article by Evan M. Wooten and Lei Shen

By now, businesses with an interest in data security are aware of FTC v. Wyndham Worldwide Corp., in which a US District Court of New Jersey held that the Federal Trade Commission (FTC) can bring enforcement actions for perceived data-security violations without first issuing guidance or standards.1 But observers may be less familiar with LabMD, a Georgia-based medical laboratory, which has waged its own challenge against the FTC for the better part of four years.

Over the past decade, the FTC has gradually increased its data-security efforts, culminating in more than 50 settlements of FTC investigations and enforcement actions. Two companies—LabMD and Wyndham—refused to settle. Instead, these two companies have been contesting the FTC's authority to regulate data security under Section 5 of the FTC Act, which empowers the FTC "to prevent persons ... from using unfair or deceptive acts or practices in or affecting commerce."2 A New Jersey District Court denied Wyndham's motion to dismiss, but certified the company's immediate appeal to the Third Circuit.3 All eyes in the privacy world are on the Third Circuit, which is still mulling Wyndham's petition, but the LabMD saga, with its many twists and turns, bears watching, as well, particularly in light of recent developments.

LabMD's legal dispute with the FTC began nearly five years ago, when a cyberintelligence company called Tiversa—specializing in peer-to-peer (P2P) network searches—purportedly disclosed that LabMD patient information was publicly available on a P2P network called LimeWire. In 2010, the FTC commenced an investigation, alleging that a LabMD billing manager made patient information available on LimeWire, including the names, birthdates, social security numbers and medical histories for nearly 9,000 patients. LabMD responded that Tiversa obtained the patient information files without its knowledge or consent and that the federal government funded Tiversa's activities. Unlike most data-security investigations, which settle at the investigative stage and end in consent decrees, the LabMD dispute quickly escalated.

According to FTC filings, LabMD produced a number of documents. However, the FTC requested more and, on August 29, 2012, brought suit in the Northern District of Georgia to compel discovery.4 On November 26, 2012, the district court ordered LabMD to comply, but the added discovery did not lead to resolution. Instead, the FTC commenced an administrative enforcement action against LabMD on August 28, 2013, alleging that the company failed to reasonably protect patient data and that data from nearly 500 patients had fallen into the hands of identify thieves.5 Meanwhile, Michael Daugherty, LabMD's president and CEO, leveled sharp criticisms against the FTC through press statements, social media and a book he wrote titled The Devil Inside the Beltway. In addition, the company launched a flurry of legal challenges.

On November 12, 2013, LabMD asked the FTC to dismiss the administrative action, arguing that the FTC lacked statutory authority to address data security and that the FTC's failure to promulgate data-security standards deprived LabMD of fair notice and constitutional due process. Two days later, LabMD took the same arguments to the US District Court for the District of Columbia, filing suit to enjoin the enforcement action as beyond the FTC's authority.6 Four days after that, LabMD filed an emergency motion in the Eleventh Circuit Court of Appeals, seeking to stay the FTC enforcement action.7 None of these actions were successful.

The FTC denied the challenge to its own authority on January 16, 2014. In February 2014, the Eleventh Circuit dismissed LabMD's emergency motion, stating that it lacked subject matter jurisdiction over anything but an FTC "cease and desist" order. The next day, LabMD voluntarily dismissed the DC District Court case.

In the midst of these defeats, LabMD announced in January 2014 that it would wind down operations, citing "the debilitating effects" of the FTC enforcement action as the impetus.8 But while the business wound down, litigation only intensified, as LabMD launched another round of attacks against the FTC's authority.

In March 2014, LabMD filed suit in the Northern District of Georgia, once again seeking to enjoin the FTC enforcement action. The district court dismissed the case in May 2014 because the FTC had yet to take a reviewable "final agency action"; the court found no authority to enjoin ongoing agency proceedings. Three days later, LabMD appealed the district court's decision to the Eleventh Circuit. As before, the Eleventh Circuit denied the motion for want of jurisdiction, this time in a one-sentence order. LabMD also moved for summary adjudication before the FTC in May 2014, again without success.

Just when a full administrative trial (and final agency action) seemed inevitable, a surprising development threw the LabMD dispute into disarray. Soon after the administrative trial began, the administrative law judge (ALJ) received information that former Tiversa employee Richard Wallace was preparing to speak with the House Oversight and Government Reform Committee (the "House Committee") regarding Tiversa's disclosures to the FTC in exchange for immunity. Through his attorney, Wallace indicated he would exercise his Fifth Amendment rights if called upon to testify before the ALJ. The ALJ immediately called a two-week recess while the House Committee continued its investigation, which included testimony from other witnesses, such as Tiversa CEO Robert Boback. On June 11, 2014, House Committee Chairman Darrell Issa (R-Cal.) sent a letter to FTC chairwoman Edith Ramirez, explaining that prior Tiversa testimony to the FTC was "incomplete and inaccurate."

When administrative trial resumed the next day, Wallace's attorney gave the letter to the ALJ, who had little choice but to adjourn the proceedings, expressing disappointment that the FTC did not present the letter itself. On June 24, 2014, LabMD petitioned the Eleventh Circuit to reopen the district court's review of the FTC's actions. The Court of Appeals is unlikely to reach a different decision at this stage, but the dispute draws ever closer to final agency action, which could trigger review by the Georgia District Court and Eleventh Circuit. That review could easily occur before review in Wyndham, especially if the Third Circuit passes on the pending interlocutory appeal.

Meanwhile, the House Committee investigation could significantly alter the course of the FTC proceedings, fueling the fire of those that, like LabMD, argue that the FTC should not have such broad authority over data security. On July 24, 2014, LabMD CEO Daugherty testified before the House Committee that Tiversa only approached the FTC—and the FTC only began its investigation—after LabMD refused to pay Tiversa's bills. Another company (Open Door Clinic) also told the House Committee that it received inquiries from the FTC after disputing Tiversa's bills.

For its part, the House Committee is reserving judgment until the investigation concludes, but the early results raise serious questions regarding the FTC's investigation. Companies with an interest in data security and the FTC's authority should pay close attention to the LabMD dispute going forward.


1 FTC v. Wyndham Worldwide Corp., No. 13-1887 (D.N.J. April 7, 2014).
2 15 U.S.C. § 45(a).
3 FTC v. Wyndham Worldwide Corp., No. 13-1887 (D.N.J. June 23, 2014).
4 FTC v. LabMD, No. 1:12-cv-3005 (N.D. Ga. Nov. 26, 2012).
5 In re LabMD, FTC Docket No. 8357 (Aug. 28, 2013).
6 LabMD v. FTC, No. 1:13-cv-01787 (D.D.C. Nov. 14, 2013).
7 LabMD v. FTC, No. 13-15267-F (11th Cir. Nov. 15, 2013).
8 Michael J. Daugherty, FTC Actions Force LabMD to Wind Down Operations (Jan. 28, 2014), http://michaeljdaugherty.com/2014/01/29/labmd-winds-operations/.

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2014. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Global Advertising Lawyers Alliance (GALA)
Frankfurt Kurnit Klein & Selz
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Global Advertising Lawyers Alliance (GALA)
Frankfurt Kurnit Klein & Selz
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions